Names | |
---|---|
IUPAC name
Pregnanedione; 5β-Pregnane-3,20-dione
|
|
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
|
|
Properties | |
C21H32O2 | |
Molar mass | 316.47758 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
5β-Dihydroprogesterone (5β-DHP), also known as pregnanedione, as well as 5β-pregnane-3,20-dione, is an endogenous neurosteroid and an intermediate in the biosynthesis of pregnanolone and epipregnanolone from progesterone. It is synthesized from progesterone by the enzyme 5β-reductase. 5β-DHP has been found to act as a positive allosteric modulator of the GABAA receptor (albeit with an affinity for this receptor regarded as relatively low (in comparison to 3α-hydroxylated progesterone metabolites such as pregnanolone and allopregnanolone)) and also as a negative allosteric modulator of the GABAA-rho receptor. In accordance with the former action, it is reported to possess anesthetic, anxiolytic, and antinociceptive effects. 5β-DHP has been found to act as an agonist of the pregnane X receptor (PXR) as well (albeit weakly (EC50 >10,000 µM)), and has been found to regulate uterine contractility through activation of this receptor. Unlike 5α-dihydroprogesterone, 5β-DHP does not possess affinity for the progesterone receptor, and hence, is not a progestogen.